Form 4: H.B. Fuller Executive VP and CFO John J. Corkrean Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Executive VP and CFO of H.B. Fuller, John J. Corkrean, filed a Form 4 detailing changes in beneficial ownership, including the acquisition of phantom units and adjustments to stock options and restricted stock units.

Summary

  • On April 29, 2024, John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 with the SEC.
  • The filing reports changes in beneficial ownership of H.B. Fuller securities.
  • Corkrean directly owns 47,187 shares of common stock.
  • The report details the acquisition of 105.67 phantom units on April 26, 2024, which convert into common stock on a 1-for-1 basis.
  • The filing also includes information on employee stock options and restricted stock units held by Corkrean, with various vesting schedules and expiration dates.

Sentiment

Score: 5

Explanation: This is a routine filing, so the sentiment is neutral. It simply reflects changes in beneficial ownership.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings and transactions of company insiders.

Comparison to Industry Standards

  • Executive compensation packages, including stock options and restricted stock units, are common across publicly traded companies like H.B. Fuller.
  • Companies such as Sherwin-Williams (SHW) and PPG Industries (PPG) also utilize similar equity-based compensation strategies to align executive interests with shareholder value.
  • Vesting schedules and exercise prices are typically benchmarked against industry peers to ensure competitiveness and retention.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding executive compensation and ownership.
  • Employees holding stock options and restricted stock units are directly impacted by the vesting schedules and stock price performance.

Key Dates

DateDescription
05/17/2017Date of employee stock option (Right-to-Buy) with an exercise price of $43.48
01/26/2018Date of employee stock option (Right-to-Buy) with an exercise price of $50.1
01/25/2019Date of employee stock option (Right-to-Buy) with an exercise price of $53.57
01/24/2020Date of employee stock option (Right-to-Buy) with an exercise price of $45.05
01/24/2021Date of employee stock option (Right-to-Buy) with an exercise price of $48.35
01/24/2023Date of employee stock option (Right-to-Buy) with an exercise price of $72.94 and restricted stock units vesting in three annual installments
01/24/2024Date of employee stock option (Right-to-Buy) with an exercise price of $68.17 and restricted stock units vesting in three annual installments
01/27/2022Date of employee stock option (Right-to-Buy) with an exercise price of $51.89
01/26/2025Date of employee stock option (Right-to-Buy) with an exercise price of $77.72 and restricted stock units vesting in three annual installments
05/17/2026Expiration date of employee stock option (Right-to-Buy) with an exercise price of $43.48
01/26/2027Expiration date of employee stock option (Right-to-Buy) with an exercise price of $50.1 and expiration date of restricted stock units vesting in three annual installments
01/25/2028Expiration date of employee stock option (Right-to-Buy) with an exercise price of $53.57
01/24/2029Expiration date of employee stock option (Right-to-Buy) with an exercise price of $45.05
01/24/2030Expiration date of employee stock option (Right-to-Buy) with an exercise price of $48.35
01/27/2031Expiration date of employee stock option (Right-to-Buy) with an exercise price of $51.89
01/24/2032Expiration date of employee stock option (Right-to-Buy) with an exercise price of $72.94
01/24/2033Expiration date of employee stock option (Right-to-Buy) with an exercise price of $68.17
01/26/2034Expiration date of employee stock option (Right-to-Buy) with an exercise price of $77.72
04/26/2024Transaction date for acquisition of phantom units
04/29/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.